SNY logo

SNY
Sanofi-Aventis

5,819
Mkt Cap
$114.26B
Volume
1.46M
52W High
$55.73
52W Low
$43.32
PE Ratio
19.85
SNY Fundamentals
Price
$47.60
Prev Close
$47.89
Open
$47.95
50D MA
$46.46
Beta
0.29
Avg. Volume
3.85M
EPS (Annual)
$2.41
P/B
1.37
Rev/Employee
$643,658.13
$134,040.08
Loading...
Loading...
News
all
press releases
Regeneron Wins FDA Nod for Extended Eylea HD Dosing Interval
REGN wins FDA nod to extend Eylea HD dosing to 20 weeks, boosting flexibility for wAMD and DME patients while reinforcing its push to offset declining Eylea sales.
Zacks·6h ago
News Placeholder
More News
News Placeholder
Aberdeen Group plc Buys 86,314 Shares of Sanofi $SNY
Aberdeen Group plc lifted its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 22.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The...
MarketBeat·18h ago
News Placeholder
Sanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host Disease
SNY secures EU conditional approval for Rezurock to treat chronic GVHD in adults and children aged 12 years and older.
Zacks·6d ago
News Placeholder
AZN Stock Gains as COPD Drug Clears Two Late-Stage Studies
AstraZeneca jumps as tozorakimab hits primary goals in two phase III COPD trials, cuts exacerbations and shows promise in a disease with limited options.
Zacks·8d ago
News Placeholder
Sanofi Reports Positive Phase 3 Results For Amlitelimab In Atopic Dermatitis
(RTTNews) - Sanofi SA (SNY, SNYNF,SAN.PA) announced encouraging results from three Phase 3 clinical trialsCOAST 1, COAST 2, and SHOREevaluating amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L). The studies, present...
Nasdaq News: Markets·9d ago
News Placeholder
Dynamic Advisor Solutions LLC Decreases Stock Holdings in Sanofi $SNY
Dynamic Advisor Solutions LLC reduced its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 87.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,290 shares of the company's stock after selling 52,401 shares du...
MarketBeat·10d ago
News Placeholder
Top Research Reports for Palantir, Linde and Arista Networks
Today's Research Daily features new research reports on 16 major stocks, including Palantir Technologies Inc. (PLTR), Linde plc (LIN) and Arista Networks, Inc. (ANET), as well as two micro-cap stocks, Comstock Holding Companies, Inc. (CHCI) and United Bancorp, Inc. (UBCP).
Zacks·10d ago
News Placeholder
Denali Wins FDA Nod for Hunter Syndrome Drug, Stock Up
DNLI surges after FDA approves Avlayah, its first commercial drug and a breakthrough Hunter syndrome therapy targeting the brain.
Zacks·11d ago
News Placeholder
REGN Soars 28.9% in Six Months: Is There More Upside Potential in 2026?
Regeneron's rally reflects biotech momentum as pipeline wins and Dupixent growth offset Eylea erosion amid intensifying competition.
Zacks·12d ago
News Placeholder
Bipartisan US Senators Reportedly Reach Breakthrough To Cap Insulin Prices at $35 – SNY, LLY, NVO Stocks Gain Pre-Market
The proposal needs the backing of Senate Majority Leader John Thune and the approval of President Donald Trump, the report added.
Stocktwits·13d ago
<
1
2
...
>

Latest SNY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.